OXAPROZIN

NDC product · U.S. Food and Drug Administration (openFDA) · United States

  • Product NDC 62135-176
  • Package NDC 62135-176-18
  • Package NDC 62135-176-60
  • Application number ANDA075987
  • SPL ID 2526421a-bb2b-1e0b-e063-6394a90a42fc
  • SPL set ID db349233-9f09-471c-aeee-f91338d2ffe9
  • UNII MHJ80W9LRB
  • RxCUI 312132

What the source publishes

Labeler
Chartwell RX, LLC.
Active ingredients
OXAPROZIN
Form
TABLET
Routes
ORAL
Administrative status
present-in-source-snapshot
Marketing status
ANDA
Product type
HUMAN PRESCRIPTION DRUG
Prescription
Prescription or restricted

Names this record is found by

Complete source data
us:fda:ndc:62135-176_2526421a-bb2b-1e0b-e063-6394a90a42fc
{
  "name": "OXAPROZIN",
  "splId": "2526421a-bb2b-1e0b-e063-6394a90a42fc",
  "labels": [
    {
      "setId": "db349233-9f09-471c-aeee-f91338d2ffe9",
      "labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=db349233-9f09-471c-aeee-f91338d2ffe9",
      "labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=db349233-9f09-471c-aeee-f91338d2ffe9"
    }
  ],
  "routes": [
    "ORAL"
  ],
  "labeler": "Chartwell RX, LLC.",
  "finished": true,
  "packaging": [
    {
      "sample": false,
      "description": "180 TABLET in 1 BOTTLE (62135-176-18)",
      "package_ndc": "62135-176-18",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20220822"
    },
    {
      "sample": false,
      "description": "60 TABLET in 1 BOTTLE (62135-176-60)",
      "package_ndc": "62135-176-60",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20220822"
    }
  ],
  "productId": "62135-176_2526421a-bb2b-1e0b-e063-6394a90a42fc",
  "useDomain": "unknown",
  "dosageForm": "TABLET",
  "productNdc": "62135-176",
  "deaSchedule": null,
  "genericName": "OXAPROZIN",
  "productType": "HUMAN PRESCRIPTION DRUG",
  "listingStatus": "present-in-source-snapshot",
  "targetSpecies": [],
  "approvalStatus": "not-established-by-ndc-listing",
  "labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
  "marketingEndDate": null,
  "activeIngredients": [
    {
      "name": "OXAPROZIN",
      "strength": "600 mg/1"
    }
  ],
  "applicationNumber": "ANDA075987",
  "marketingCategory": "ANDA",
  "stateRestrictions": {
    "status": "not-collected",
    "observations": []
  },
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "us.fda.ndc"
  },
  "marketingStartDate": "20040902",
  "targetSpeciesStatus": "not-reported",
  "prescriptionCategory": "prescription-or-restricted",
  "harmonizedIdentifiers": {
    "nui": [
      "N0000000160",
      "M0001335",
      "N0000175722"
    ],
    "upc": [
      "0362135176600",
      "0362135176181"
    ],
    "unii": [
      "MHJ80W9LRB"
    ],
    "rxcui": [
      "312132"
    ],
    "spl_set_id": [
      "db349233-9f09-471c-aeee-f91338d2ffe9"
    ],
    "pharm_class_cs": [
      "Anti-Inflammatory Agents, Non-Steroidal [CS]"
    ],
    "pharm_class_epc": [
      "Nonsteroidal Anti-inflammatory Drug [EPC]"
    ],
    "pharm_class_moa": [
      "Cyclooxygenase Inhibitors [MoA]"
    ],
    "manufacturer_name": [
      "Chartwell RX, LLC."
    ],
    "is_original_packager": [
      true
    ]
  },
  "listingExpirationDate": "20261231"
}

Read this record from your own software

The same record, with every field and its provenance, is one request away. An API key is free and works immediately.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=us" \
  --data-urlencode "sourceId=us.fda.ndc" \
  --data-urlencode "id=us:fda:ndc:62135-176_2526421a-bb2b-1e0b-e063-6394a90a42fc"